(Q38597247)

4 September 2017

title

Epstein-Barr Virus Lytic Cycle Reactivation (English)

1 reference

4 September 2017

0 references

Jessica McKenzie

1

1 reference

4 September 2017

Ayman El-Guindy

series ordinal

2

1 reference

4 September 2017

publication date

1 January 2015

1 reference

Current Topics in Microbiology and Immunology

4 September 2017

published in

1 reference

4 September 2017

volume

391

1 reference

4 September 2017

page(s)

237-261

1 reference

Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Lytic cycle gene regulation of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Cellular transcription factors recruit viral replication proteins to activate the Epstein-Barr virus origin of lytic DNA replication, oriLyt

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Activation of the epstein-barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

CpG-methylation regulates a class of Epstein-Barr virus promoters

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBV-seropositive individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Lytic Epstein-Barr virus infection in epithelial cells but not in B-lymphocytes is dependent on Blimp1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

MCAF1 and synergistic activation of the transcription of Epstein-Barr virus lytic genes by Rta and Zta.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Antibody response to Epstein-Barr-virus-specific DNase in 13 patients with nasopharyngeal carcinoma in Taiwan: a retrospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

A general mechanism for transcriptional synergy by eukaryotic activators

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Architecture of replication compartments formed during Epstein-Barr virus lytic replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Disruption of Epstein-Barr virus latency in the absence of phosphorylation of ZEBRA by protein kinase C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Identification of constitutive phosphorylation sites on the Epstein-Barr virus ZEBRA protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Phosphoacceptor site S173 in the regulatory domain of Epstein-Barr Virus ZEBRA protein is required for lytic DNA replication but not for activation of viral early genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

A Subset of Replication Proteins Enhances Origin Recognition and Lytic Replication by the Epstein-Barr Virus ZEBRA Protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Essential role of Rta in lytic DNA replication of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

A locus encompassing the Epstein-Barr virus bglf4 kinase regulates expression of genes encoding viral structural proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Cellular MicroRNAs 200b and 429 Regulate the Epstein-Barr Virus Switch between Latency and Lytic Replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Effectiveness of aggressive prophylatic and preemptive therapies targeted against cytomegaloviral and Epstein-Barr viral disease after human intestinal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Replication of Epstein-Barr viral DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Genome-wide analysis of Epstein-Barr virus Rta DNA binding

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Histone acetylation and reactivation of Epstein-Barr virus from latency.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Regulation of the latent-lytic switch in Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Spectrum of Epstein-Barr virus-associated diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Compensatory energetic relationships between upstream activators and the RNA polymerase II general transcription machinery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

A mechanism for TAFs in transcriptional activation: activation domain enhancement of TFIID-TFIIA--promoter DNA complex formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

A role for the nucleosome assembly proteins TAF-Iβ and NAP1 in the activation of BZLF1 expression and Epstein-Barr virus reactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Smad phosphoisoform signaling specificity: the right place at the right time

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Regulation of the Epstein-Barr virus Zp promoter in B lymphocytes during reactivation from latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Lytic cycle switches of oncogenic human gammaherpesviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Involvement of Jun dimerization protein 2 (JDP2) in the maintenance of Epstein-Barr virus latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The interaction of mitogen-activated protein kinases to Epstein-Barr virus activation in Akata cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Downregulation of microRNA-200 in EBV-associated gastric carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Replication of Epstein–Barr virus in human epithelial cells infected in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus immediate-early protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Endoplasmic reticulum stress causes EBV lytic replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Activation of latent Epstein–Barr virus by antibody to human IgM

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs d

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Identification of Herpes TATT-binding protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-beta1 mediated reactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Latency of Epstein-Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Virus and cell RNAs expressed during Epstein-Barr virus replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

Persisting oncogenic herpesvirus induced by the tumour promoter TPA

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22834-1_8

10.1007/978-3-319-22834-1_8

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference